Search results
Annie F. Luetkemeyer (born April 13, 1972, Baltimore, Maryland, U.S.) is an American physician and researcher who is Professor of Medicine and Infectious Diseases at the University of California, San Francisco.
HIV, Infectious Disease, and Global Medicine, Infectious Diseases. Interests: HIV therapeutic strategies, COVID-19 treatment and prevention, Sexually Transmitted Infections, DoxyPEP, Viral hepatitis, Hepatitis C, Hepatitis Elimination. Clinical Trials:
Annie Luetkemeyer, MD. Education and Training. Interests. Websites. In The News. Clinical Trials. Academic Senate. Twitter. Publications. Education and Training. Interests. HIV therapeutic strategies, COVID-19 treatment and prevention, Sexually Transmitted Infections, DoxyPEP, Viral hepatitis, Hepatitis C, Hepatitis Elimination. Websites.
annie.luetkemeyer@ucsf.edu. +1 415 502-5753. I specialize in HIV/AIDS and have clinical responsibilities including outpatient services at the San Francisco General Hospital HIV clinic as well as inpatient services on the HIV/AIDS, general medicine, and infectious diseases consult services. I direct the HIV Clinical Trials Group at SFGH, which ...
It’s a rare day when Annie Luetkemeyer, MD, puts in fewer than 12 hours at Zuckerberg San Francisco General Hospital. A UCSF physician-researcher, Luetkemeyer previously helped advance effective HIV drugs and a cure for hepatitis C.
Comparison of Quantiferon to Conventional Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection (LTBI) in HIV Positive Subjects. Mentored Scientist Award, Spring 2005.
Annie Luetkemeyer was among a panel of doctors interviewed in a SF Chronicle article regarding their work in understanding COVID-19 and their efforts towards developing a treatment.
